Glucagon-Like Peptide 1 Receptor Agonist Is Associated With Improved Survival in Overweight Heart Failure Patients
This nationwide real-world study shows that patients with HF who received GLP-1RA have a significant reduction in CV mortality, which is particularly pronounced in overweight and obese patients with reduced ejection fraction.
Authors
- Michael Fu (ORCID: https://orcid.org/0000-0003-3507-6059)
- Patric Karlström (ORCID: https://orcid.org/0000-0002-2441-0245)
- Aldina Pivodic (ORCID: https://orcid.org/0000-0002-2224-3236)
Institutions
- Sahlgrenska University Hospital (SE)
- Ryhov Hospital Jönköping (SE)
- Linköping University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- JACC Heart Failure
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1016/j.jchf.2024.12.004
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.36